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INTRODUCTION
Renal cell carcinoma (RCC) represents 4% of all new 
diagnosed malignancies, with over 62,000 new cases expected 
in 2016 [1]. Many of these newly diagnosed malignancies 
include incidental, small, and localized lesions, attributable 
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to the widespread use of abdominal imaging modalities [2]. 
Surgical management with partial nephrectomy (PN) is the 
standard approach for most small renal lesions concerning 
for RCC, with very favorable outcomes [3,4]. Imaging moda­
lities are highly useful for stratifying patients at risk for 
renal malignancy; however, upwards of  30% of  excised 
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lesions ultimately show benign pathology [5]. While there 
are certainly indications for excision of  benign tumors, 
these lesions are often unnecessarily surgically excised 
due to ambiguity of  diagnosis and risk of  malignancy. 
Distinguishing oncocytoma or lipid­poor angiomyolipoma 
(AML) from RCC is difficult [6­8], and it is clear that better 
preoperative risk models are needed to prevent unnecessary 
surgeries for benign lesions.
AMLs are benign kidney lesions that are normally 
distinguished from RCC on imaging due to fat content. 
RCC rarely contains macroscopic adiposity, while close to 
5% of AMLs do not exhibit macroscopic fat upon standard 
imaging and are classified as “lipid­poor AML” [7,8]. Previous 
studies have used imaging characteristics to help with 
distinguishing lipid­poor AML from RCC [9­16]. Despite this 
progress, detection of lipid­poor AML remains difficult, and 
directly conflicting results exist in the literature for some 
imaging findings [15,16]. While there is a noted association 
of AML with age and sex [17], there are few models that 
accurately predict lipid­poor AML using preoperative patient 
characteristics. Therefore, the objective of this study was to 
use clinical variables to create a simple model for predicting 
lipid­poor AML in patients with small renal masses 
presumed to be RCC from preoperative imaging.
MATERIALS AND METHODS
1. Patient cohort
The Washington University Institutional Review Board 
approved the prospective collection of patient data used in 
this study (approval number: 201304085). Using a consented, 
de­identified, prospectively maintained database, all patients 
undergoing PN between 2007 and 2015 were retrospectively 
identified. Only patients with preoperative imaging suspi­
cious for malignancy were included, and this was defined as 
solid enhancing masses or complicated renal cysts classified 
as Bosniak category III or IV [18]. Patient were excluded if 
given a previous diagnosis of von Hippel­Landau syndrome, 
tuberous sclerosis, or Birt­Hogg­Dubé syndrome, or if more 
than one renal mass was resected or preoperative imaging 
was suspicious for benign lesions. The final cohort of 
patients underwent a single PN for a single renal lesion 
with curative intent for presumed RCC.
2. Surgical technique
Surgical approach was impacted by the following fac­
tors: patient habitus, tumor location, history of  abdomi­
nal surgery, and surgeon and patient preference. A 
transperitoneal approach was used for laparoscopic 
operations with clamping of the renal vessels [19]. Open PN 
was used for larger endophytic tumors and was based on 
surgeon preference. Robotic­assisted PN (RAPN) operations 
were performed with a retroperitoneal or transperitoneal 
approach [20]. Off­clamp technique was chosen based on 
tumor location, patient characteristics, and surgeon pre­
ference [21].
3. Data collection
Staff  data managers and physicians prospectively 
collected patient demographics, perioperative outcomes, 
and tumor characteristics. AML was considered “lipid­
poor” and was included in this study if adiposity was not 
observed on preoperative imaging and if  the lesion was 
considered suspicious for malignancy. Preoperative computed 
tomography (CT) or magnetic resonance imaging (MRI) was 
interpreted by fellowship­trained genitourinary radiologists 
before the time of surgery, and genitourinary pathologists 
were responsible for making the final diagnosis.
4. Statistical analysis
Chi­square analysis, Fisher exact test, or Mann­Whitney 
U­test were used to evaluate the association of preoperative 
variables with lipid­poor AML. Logistic regression was 
used for multivariable modeling of predictors of lipid­poor 
AML using the following variables: sex, age at surgery, 
preoperative hemoglobin, history of  hypertension, and 
tumor size. Point values for the final model were created 
by normalization of odds ratios to the lowest value from 
multivariate analysis, where the lowest odds ratio was 
assigned a point value of one. All analysis was performed 
using R v3.1.3 (R Foundation for Statistical Computing, 
Vienna, Austria), and a 2­tailed p­value <0.05 was considered 
significant in all analyses.
RESULTS
A total of 730 patients underwent PN at our institution 
between 2007–2015 for renal masses ≤4 cm, including 110 
patients (15.1%) with benign pathology upon final diagnosis 
(Table 1). Of these 110 patients, 35 patients (31.8%) were 
diagnosed with AML. All cases of AML were retrospectively 
confirmed to be lipid­poor AML by evaluation of surgical 
pathology reports.
Differences in patient characteristics between patients 
with RCC (n=620) and lipid­poor AML (n=35) were then 
investigated (Supplementary Table 1). Compared to patients 
with RCC, patients with AML were significantly younger 
(p=0.01), more likely to be female (p<0.001), had smaller 
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tumors (p<0.001) and lower nephrometry (p=0.003) scores, 
were less likely to have hypertension (p=0.02), and had lower 
preoperative creatinine (p<0.001) and hemoglobin (p=0.04). 
Within individual components of the nephrometry score, 
tumors in lipid­poor AML patients were located further 
from the collecting system (low N) (p=0.02) and were more 
likely to be highly exophytic (low E) (p=0.001). There was 
no significant difference in body mass index, comorbidity 
status, tumor laterality, anterior/posterior tumor location, 
tumor location relative to polar lines, or presence of diabetes 
mellitus between patients with RCC and lipid­poor AML.
A multivariable model was constructed to compare fea­
tures and demographics of ≤4-cm masses in AML and RCC 
patients (Table 2). The following features independently 
predicted AML: female sex (odds ratio, 6.89; 95% confidence 
interval, 2.35–20.92; p<0.001), age <56 years (2.84; 1.21–6.66; 
p=0.02), and tumor size <2 cm (5.87; 2.70–12.77; p<0.001).
We hypothesized that these features could be used to 
create a simple model to distinguish lipid­poor AML from 
RCC in patients with ≤4-cm renal masses (Table 3). Sex, 
age, and tumor size were used to construct the BEnign 
Angiomyolipoma Renal Susceptibility (BEARS) index, where 
the following point values were assigned for each particular 
risk factor: female sex (2 points), age <56 (1 point), and 
tumor size <2 cm (2 points). Within the study population, the 
BEARS index distinguished AML from RCC lesions with an 
area under the curve of 0.84 (p<0.0001) (Fig. 1). Probability 
estimates for predicting lipid­poor AML were generated 
based of BEARS index values (Supplementary Table 2).
DISCUSSION
The ability to distinguish benign from malignant 
renal lesions preoperatively is important for preventing 
unnecessary surgeries, undue morbidity, and excessive 
medical costs. However, benign lesions such as oncocytoma 
and lipid­poor AML cannot be reliably distinguished from 
RCC with standard imaging modalities [6­8]. Previous studies 
have investigated whether preoperative characteristics 
can predict benign histology after PN [22,23]. Both Jeon et 
al. [23] and Fujita et al. [22] reported that female sex and 
age at surgery were independently predictive of  benign 
lesions. Further, Jeon et al. [23] found that earlier year of 
surgery was associated with benignity, while Fujita et al. [22] 
observed a relationship of exophyticity with benign lesions. 
Interestingly, AML was highly represented in the cohorts 
from Jeon et al. [23] (43.2% AML) and Fujita et al. [22] (41.6% 
AML), which led us to hypothesize that the high AML 
representation was driving the predictive factors observed 
Table 1. Demographics of patients undergoing partial nephrectomy 
for ≤4-cm lesions presumed to be RCC from preoperative imaging
Characteristic Value
Type of partial nephrectomy
   Open 26 (3.6)
   Laparoscopic 84 (11.5)
   RAPN 615 (84.2)
   Laparoscopic converted to open 1 (0.1)
   RAPN converted to open 4 (0.5)
History of diabetes
   No 515 (78.7)
   Yes 139 (21.3)
   Missing data 76
History of hypertension
   No 254 (38.8)
   Yes 400 (61.2)
   Missing data 76
Tumor laterality
   Left 344 (47.1)
   Right 386 (52.9)
Perioperative complications
   No complications 589 (88.8)
   Complications 74 (11.2)
   Missing data 67
Perioperative blood transfusion
   No transfusion 635 (95.5)
   Perioperative transfusion 30 (4.5)
   Missing data 65
Charlson comorbidity index
   0 342 (52.2)
   1 135 (20.6)
   2 93 (14.2)
   ≥3 84 (12.8)
   Missing 76
Tumor histology
   Benign 110 (15.1)
      Angiomyolipoma 35 (31.8)
      Oncocytoma 55 (50.0)
      Complex cyst 6 (5.5)
      Other 14 (12.7)
   Malignant 620 (84.9)
Age at surgery (y) (n=730) 57.5±12.1
Body mass index (kg/m2) (n=698) 30.6±6.9
Nephrometry score (n=544) 7.2±1.8
Radiographic tumor size (cm) (n=730) 2.5±0.8
Preoperative hemoglobin (g/dL) (n=611) 13.9 (1.5)
Preoperative creatinine (mg/dL) (n=658) 0.93 (0.34)
Values are presented as number (%) or mean±standard deviation.




in these studies. This was further corroborated by our 
institutional experience, where sex and age did not predict 
benignity in a cohort of patients with higher oncocytoma 
representation (51.2%) and a lower proportion of AML (28.6%).
There is a known association of  AML with middle­
aged females [17], and in this study, both age and sex were 
strong predictors of lipid­poor AML in multivariate analysis, 
suggesting that these variables also apply to lipid­poor AML 
in addition to lipid­rich AML. Interestingly, we limited our 
cohort to patients with tumors ≤4 cm given the small size 
of  most lipid­poor AMLs and difficulty in management 
of small renal masses [24]. Despite limiting our cohort to 
tumors ≤4 cm, tumor size was the second strongest predictor 
of  AML in our patients, with an odds ratio of  5.87. By 
combining these variables to create the BEARS index, we 
were able to accurately distinguish lipid­poor AML from 
RCC with an AUC of 0.84. From these data, we conclude 
that younger female patients with renal tumors <2 cm are 
at high risk of having AML instead of RCC, and alternative 
management decisions, including possible biopsy, should be 
considered before extirpative therapy in these patients.
Previously, multiple studies have used imaging features 
in attempt to distinguish lipid­poor AML from RCC and 
other lesions [9­16]. Authors have found myriad predictive 
factors of lipid­poor AML, including high attenuation on 
unenhanced CT [14,25,26], a low T2­weighted signal intensity 
on MRI [11,12], and homogenous tumor enhancement on 
contrast CT [13,14], among other factors. However, it has 
been historically challenging to reliably distinguish lipid­
poor AML from RCC based upon radiographic data alone 
[6­8]. There is difficulty in replicating results from previous 
studies, as conflicting results exist in the literature for some 
Table 2. Multivariable analysis of preoperative predictors of angiomyolipoma vs. malignant histology in renal masses ≤4 cm
Characteristic Odds ratio (95% CI) p-value
Sex
   Male Reference -
   Female 6.89 (2.35–20.92) <0.001
Age at surgery (y)
   ≥56 Reference -
   <56 2.84 (1.21–6.66) 0.02
Radiographic tumor size (cm)
   ≥2 Reference
   <2 5.87 (2.70–12.77) <0.001
History of hypertension
   No Reference
   Yes 0.60 (0.27–1.36) 0.22
Preoperative hemoglobin (g/dL) 0.96 (0.71–1.30) 0.81
CI, confidence interval.
Fig. 1. Receiver operating characteristic analysis of the ability of the BE-
nign Angiomyolipoma Renal Susceptibility (BEARS) index to differentiate 
lipid-poor angiomyolipoma and renal cell carcinoma in renal masses ≤4 
cm. The BEARS index was calculated for each patient using sex, tumor 
size, and age at surgery. The index significantly predicted lipid-poor an-


























   Male 0
   Female 2
Age at surgery (y)
   ≥56 0
   <56 1
Radiographic tumor size (cm)
   ≥2 0
   <2 2
BEARS, BEnign Angiomyolipoma Renal Susceptibility.
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imaging results [15,16]. Further, most patients receive either 
MRI or CT imaging, but not both modalities; therefore, 
imaging studies where only one modality is used limits 
applicability to all patients. Herein, we introduce the BEARS 
index, a simple model to predict the likelihood of AML in 
patients with small renal masses ≤4 cm. This model was 
highly accurate in classifying patients with masses ≤4 cm 
as lipid­poor AML, and the included components are readily 
available at most institutions, substantially increasing the 
potential clinical applicability. Through risk stratification 
and preoperative counseling, simple models such as the 
BEARS index may significantly reduce the number of 
patients undergoing unnecessary PN for benign lesions.
Limitations of the current study are inherently attri­
butable to the retrospective design. There was variability 
in imaging protocols used for renal mass characterization. 
The number of patients with lipid­poor AML is a limitation, 
though few studies exist with larger cohorts. The BEARS 
index was created from and validated in the same cohort of 
patients; while the index was accurate in classifying AML in 
this set of patients, the instrument still needs to be validated 
externally.
CONCLUSIONS
Young female patients with small tumors are at risk 
for having lipid­poor AML despite preoperative imaging 
consistent with RCC. Identification of these patients may 
reduce the incidence of unnecessary PN for benign renal 
lesions.
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